Metraipolis › archive › dc_09beeb4ce2a7

Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure — Europe PMC PMID:28489753

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/28489753
DOI
10.1097/md.0000000000006769
License (as archived)
solo-consultazione
Archived
2026-11-09T04:00:47.816Z
SHA-256 of the archived text
a156cac895c6aa30db56b76c3177e29c5a410f0e13e30c66a5c3f7219f801ce3
Stable URL of this page
https://metraipolis.com/documento/dc_09beeb4ce2a7

How to cite

Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure — Europe PMC PMID:28489753 — Europe PMC (en), https://europepmc.org/article/MED/28489753 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09beeb4ce2a7 (Metraipolis archive dc_09beeb4ce2a7, sha256 a156cac895c6aa30db56b76c3177e29c5a410f0e13e30c66a5c3f7219f801ce3)
BibTeX
@misc{dc09beeb4ce2a7,
  title = {Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure — Europe PMC PMID:28489753},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28489753},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09beeb4ce2a7; sha256 a156cac895c6aa30db56b76c3177e29c5a410f0e13e30c66a5c3f7219f801ce3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28489753. Agents can read the archived copy with the MCP tool read_document.